Triglyceride-rich lipoproteins (Chylomicron and VLDL) are proven to be heterogenous in their size and chemical composition and the largerr particles are supposed to be catabolized to the smaller particles by the lipoprotein lipase (LPL). In order to investigate the VLDL metabolism, VLDL has been previously separated into subfractions by preparative ultracentrifugation, gel chromatography and so forth. Recently, it was reported that VLDL could be separated into seven subfractions by rate zonal ultracentrifugation.
In this paper, we report the compositional changes of lipoproteins, especially of VLDL subclasses, before and after the treatment with drugs which are supposed to increase the removal of TG-rich lipoproteins. We also speculate on the changes of HDL isolated by zonal ultracentrifugation.
1) The each subfraction of the VLDL is different in size and composition, and the chemical composition of VLDL subclasses was also different between the type V and type III hyperlipoproteinemias.
2) On oxandrolone treatment, the concentration of VLDL, of all VLDL subclasses and of IDL was reduced in type V patient, and the distribution of VLDL subclasses was changed remarkably, hence coming to resemble that in normal subjects.
3) In the type V patient, in whom HDL-
3 was reduced and HDL-
2 was absent, the concentration of HDL-
3 was moreover reduced after oxandrolone treatment and this HDL-
3 emerged later from the zonal rotor than before, implying increase of this HDL-
3 density.
4) Apoprotein-E (ARP), which appeared abundantly in all of the VLDL subclasses in the type V patient, disappered completely from all of the VLDL subclasses after oxandrolone treatment.
5) On clofibrate treatment, the concentration of VLDL, of VLDL subclasses and of IDL was remarkably reduced in the type III patient, and the fractions which appeared to be the chylomicron remnant and Sf-30 VLDL decreased preferencially among VLDL subclasses after treatment. Moreever, there appered another one predominant peak between the density of IDL and LDL which might be speculated as the remnant particles.
6) In this type III patient in whom the content of HDL-
3 was reduced and HDL-
2 was missing before treatment, there newly appeared HDL-
2 peak other than HDL-
3 fraction after clofibrate treatment.
7) Apoprotein-E, which was observed in high abundance throughout all the VLDL-subfractions in the type III patient, still remained predominant apoprotein in all VLDL subfractions after clofibrate treatment.
View full abstract